Shanghai MicroPort MedBot (Group) (HKG:2252) recorded a cumulative order volume of over 100 units for the laparoscopic, orthopedic, and vascular interventional core products of the group for 2024, a Friday Hong Kong bourse filing said.
39 orders were received for Toumai Laparoscopic Surgical Robot, while SkyWalker Orthopedic Surgical Robot saw an order volume of 25 units in 2024.
Moreover, R-ONE Vascular Interventional Surgical Robot won purchase order bids from five top public hospitals in Shanghai, the filing said.